The average price target for NovoCure Limited has been cut from $25.71 to $21.33.

Nov 1, 2026, 3:05 AM ETOpinionRead the original at tradingview.com

Neutral

NovoCure's average analyst target fell from $25.71 to $21.33, but 3 analysts kept buy ratings and 3 stayed neutral. The target still suggests 62% potential upside, so these mixed analyst views do not show a clear change to the company's business outlook.

NVCR · NovoCure Limited

AI read · Neutral

The AI's read

The lower estimate points to less optimism from analysts. Three kept a buy rating and 3 stayed neutral, and the new target still suggests 62% potential upside from the cited closing price. These are analyst views, not new company results, so the story does not clearly change NovoCure's business outlook.

Get alerts for NVCR

Follow NovoCure Limited (NVCR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NVCR

Free on the App Store and Google Play, or on the web.